从囊性纤维化患者中分离出的铜绿假单胞菌粗糙型、光滑型和黏液型菌落的抗菌药敏性。
Antimicrobial susceptibilities of rough, smooth, and mucoid colony types of Pseudomonas isolated from cystic fibrosis patients.
作者信息
Maybury B A, Blessing-Moore J, deWit S A, Lewiston N J, Yeager A S
出版信息
Antimicrob Agents Chemother. 1979 Mar;15(3):494-6. doi: 10.1128/AAC.15.3.494.
Abstract
Minimal inhibitory concentrations of carbenicillin, chloramphenicol, tetracycline, gentamicin, tobramycin, and trimethoprim-sulfamethoxazole were determined for rough, smooth, and mucoid Pseudomonas sp. isolates from sputa collected from 40 cystic fibrosis patients. Ninety-four percent of the minimal inhibitory concentrations obtained by using mixed inocula of colonies of different morphological types fell within one serial dilution of the most resistant minimal inhibitory concentration obtained when each colony type was tested separately.
摘要
测定了从40例囊性纤维化患者痰液中分离出的粗糙型、光滑型和黏液型假单胞菌属菌株对羧苄青霉素、氯霉素、四环素、庆大霉素、妥布霉素和甲氧苄啶-磺胺甲恶唑的最低抑菌浓度。使用不同形态类型菌落的混合接种物获得的最低抑菌浓度中，94%落在分别测试每种菌落类型时获得的最耐药最低抑菌浓度的一个连续稀释度范围内。
相似文献
1
Antimicrobial susceptibilities of rough, smooth, and mucoid colony types of Pseudomonas isolated from cystic fibrosis patients.
Antimicrob Agents Chemother. 1979 Mar;15(3):494-6. doi: 10.1128/AAC.15.3.494.
2
Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients.
J Clin Microbiol. 1979 Jan;9(1):72-8. doi: 10.1128/jcm.9.1.72-78.1979.
3
Heterogeneity of antibiotic resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins.
Antimicrob Agents Chemother. 1981 Jun;19(6):1056-63. doi: 10.1128/AAC.19.6.1056.
4
Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosis.
J Antimicrob Chemother. 1985 May;15(5):545-9. doi: 10.1093/jac/15.5.545.
5
In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
Chemotherapy. 1979;25(1):48-53. doi: 10.1159/000237821.
6
In-vitro activity of ciprofloxacin and other antibacterial agents against Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients.
J Antimicrob Chemother. 1985 Jun;15(6):679-84. doi: 10.1093/jac/15.6.679.
7
8
Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
J Chemother. 2010 Dec;22(6):378-83. doi: 10.1179/joc.2010.22.6.378.
9
Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media.
J Antimicrob Chemother. 2008 May;61(5):1057-61. doi: 10.1093/jac/dkn081. Epub 2008 Mar 3.
10
Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro.
J Antimicrob Chemother. 1978 May;4(3):233-40. doi: 10.1093/jac/4.3.233.
引用本文的文献
1
Evaluation of reference dilution test methods for antimicrobial susceptibility testing of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis.
J Clin Microbiol. 1999 Sep;37(9):2987-91. doi: 10.1128/JCM.37.9.2987-2991.1999.
2
Mixed-morphotype broth microdilution susceptibility testing of Pseudomonas aeruginosa from cystic fibrosis patients.
J Clin Microbiol. 1993 Feb;31(2):458-9. doi: 10.1128/jcm.31.2.458-459.1993.
3
Accuracy and cost of antibiotic susceptibility testing of mixed morphotypes of Pseudomonas aeruginosa.
J Clin Microbiol. 1994 Apr;32(4):1027-30. doi: 10.1128/jcm.32.4.1027-1030.1994.
4
Microbiology of airway disease in patients with cystic fibrosis.
Clin Microbiol Rev. 1991 Jan;4(1):35-51. doi: 10.1128/CMR.4.1.35.
本文引用的文献
1
A microdilution method for antibiotic susceptibility testing: an evaluation.
Am J Clin Pathol. 1970 Jun;53(6):880-5. doi: 10.1093/ajcp/53.6.880.
2
Dissociation in Pseudomonas aeruginosa.
J Bacteriol. 1964 May;87(5):1003-10. doi: 10.1128/jb.87.5.1003-1010.1964.
3
Pseudomonas aeruginosa: immune status in patients with cystic fibrosis.
Infect Immun. 1972 Oct;6(4):628-35. doi: 10.1128/iai.6.4.628-635.1972.
4
Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.
Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Aug;82(4):541-50.
5
Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis.
Acta Pathol Microbiol Scand Suppl. 1975 Dec;83(6):553-60.
6
Evaluation of the micro-media system for quantitative antimicrobial drug susceptibility testing: a collaborative study.
Antimicrob Agents Chemother. 1978 Jan;13(1):61-9. doi: 10.1128/AAC.13.1.61.
Zotero 插件